France at a glance
- Population
- 68.7 million 2025
- Life expectancy at birth
- 83.0 years, 2024
- People aged 65 and over
- 22.5 % of people, 2025
- Health spending per person
- 5,327 US$ per person, 2024
- Doctors
- 3.28 per 1,000 people, 2022
Updated
Reviewed by Chandani Patel
France Precision Medicine Platforms Market Industry Trends and Forecast to 2034: Segmented by (Component, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$432.8 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $285.4 Mn | — | — |
| 2025 (base) | $314.2 Mn | +$28.8 Mn | — |
| 2026 (forecast) | $345.9 Mn | +$31.7 Mn | +10.1% |
| 2027 (forecast) | $380.9 Mn | +$34.9 Mn | +21.2% |
| 2028 (forecast) | $419.3 Mn | +$38.5 Mn | +33.5% |
| 2029 (forecast) | $461.7 Mn | +$42.4 Mn | +46.9% |
| 2030 (forecast) | $508.3 Mn | +$46.6 Mn | +61.8% |
| 2031 (forecast) | $559.7 Mn | +$51.3 Mn | +78.1% |
| 2032 (forecast) | $616.2 Mn | +$56.5 Mn | +96.1% |
| 2033 (forecast) | $678.4 Mn | +$62.2 Mn | +115.9% |
| 2034 (forecast) | $747.0 Mn | +$68.5 Mn | +137.7% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $314.2 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $747.0 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 10.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Component, application and end user (see all) |
| Key players | Tempus, Illumina, Inc., Roche, Caris Life Sciences, Sophia Genetics (see all) |
| Regulator in France | EU MDR and ANSMSource: European Commission, medical devices. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Precision medicine platforms combine genetic, clinical and lifestyle data to tailor treatment and prevention to each person.
Key segments of the precision Medicine Platforms market include component (Software Platforms, Data Services and Testing Services) and application (Oncology, Cardiology and Rare Disease).
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the precision Medicine Platforms market.
Routine use of genomics in screening, pharmacy and primary care gives the precision Medicine Platforms market large room to grow.
Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the precision Medicine Platforms market.
The precision Medicine Platforms market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device; ANSM oversees it in France.[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.[2]
[1] European Commission, medical devices. Checked 14 Nov 2026.
[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the precision Medicine Platforms market. Government digital health programs in France are speeding up adoption.
What doctors and scientists are doing in Precision Medicine Platforms right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 18 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.
From our blog
France · 1 shared keyword
France
France
France
France
France
Pharmaceuticals · France
Healthcare Services · France
Healthcare Services · France
Medical Devices · France
Medical Devices · France
Medical Devices · France